$EXPO
EXPONENT INC

2015 Q2 Form 10-Q Financial Statement

#000114420415028813 Filed on May 08, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $80.29M $75.96M
YoY Change 5.7% 0.61%
Cost Of Revenue $4.200M $3.000M
YoY Change 40.0% -16.67%
Gross Profit $76.10M $73.00M
YoY Change 4.25% 1.53%
Gross Profit Margin 94.78% 96.1%
Selling, General & Admin $54.60M $52.60M
YoY Change 3.8% 9.36%
% of Gross Profit 71.75% 72.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400M $1.300M
YoY Change 7.69% 0.0%
% of Gross Profit 1.84% 1.78%
Operating Expenses $65.27M $61.87M
YoY Change 5.49% 6.83%
Operating Profit $15.03M $14.09M
YoY Change 6.63% -19.89%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $2.043M $1.271M
YoY Change 60.74% 87.46%
Pretax Income $17.07M $15.37M
YoY Change 11.1% -15.9%
Income Tax $6.738M $6.211M
% Of Pretax Income 39.47% 40.42%
Net Earnings $10.33M $9.154M
YoY Change 12.88% -15.62%
Net Earnings / Revenue 12.87% 12.05%
Basic Earnings Per Share $0.39 $0.34
Diluted Earnings Per Share $0.38 $0.33
COMMON SHARES
Basic Shares Outstanding 26.62M shares 27.07M shares
Diluted Shares Outstanding 27.39M shares 27.88M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.0M $137.5M
YoY Change 5.45% 11.7%
Cash & Equivalents $123.7M $105.6M
Short-Term Investments $21.40M $31.80M
Other Short-Term Assets $23.70M $27.20M
YoY Change -12.87% 45.45%
Inventory
Prepaid Expenses
Receivables $88.08M $84.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $256.8M $249.6M
YoY Change 2.88% 9.43%
LONG-TERM ASSETS
Property, Plant & Equipment $27.59M $28.31M
YoY Change -2.57% -1.56%
Goodwill $8.607M $8.607M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.159M $593.0K
YoY Change 95.45% 2.24%
Total Long-Term Assets $100.4M $92.35M
YoY Change 8.73% 7.13%
TOTAL ASSETS
Total Short-Term Assets $256.8M $249.6M
Total Long-Term Assets $100.4M $92.35M
Total Assets $357.2M $342.0M
YoY Change 4.46% 8.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.900M $12.90M
YoY Change -31.01% 115.0%
Accrued Expenses $40.20M $42.30M
YoY Change -4.96% -5.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.88M $62.40M
YoY Change -12.06% 7.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.985M $1.250M
YoY Change 58.8% 13.43%
Total Long-Term Liabilities $1.985M $1.250M
YoY Change 58.8% 13.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.88M $62.40M
Total Long-Term Liabilities $1.985M $1.250M
Total Liabilities $103.4M $100.4M
YoY Change 3.01% 10.22%
SHAREHOLDERS EQUITY
Retained Earnings $248.1M $225.6M
YoY Change 9.97% 7.13%
Common Stock $174.2M $155.7M
YoY Change 11.86% 12.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $167.0M $139.9M
YoY Change 19.41% 11.58%
Treasury Stock Shares 3.436M shares 3.293M shares
Shareholders Equity $253.8M $241.6M
YoY Change
Total Liabilities & Shareholders Equity $357.2M $342.0M
YoY Change 4.46% 8.8%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $10.33M $9.154M
YoY Change 12.88% -15.62%
Depreciation, Depletion And Amortization $1.400M $1.300M
YoY Change 7.69% 0.0%
Cash From Operating Activities $1.700M -$6.100M
YoY Change -127.87% -128.24%
INVESTING ACTIVITIES
Capital Expenditures $627.0K $915.0K
YoY Change -31.48% -47.47%
Acquisitions
YoY Change
Other Investing Activities $3.300M $1.100M
YoY Change 200.0% -64.52%
Cash From Investing Activities $2.700M $200.0K
YoY Change 1250.0% -84.62%
FINANCING ACTIVITIES
Cash Dividend Paid $4.023M $3.310M
YoY Change 21.54%
Common Stock Issuance & Retirement, Net $3.500M $6.831M
YoY Change -48.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.10M -11.60M
YoY Change -12.93% 48.72%
NET CHANGE
Cash From Operating Activities 1.700M -6.100M
Cash From Investing Activities 2.700M 200.0K
Cash From Financing Activities -10.10M -11.60M
Net Change In Cash -5.700M -17.50M
YoY Change -67.43% -215.89%
FREE CASH FLOW
Cash From Operating Activities $1.700M -$6.100M
Capital Expenditures $627.0K $915.0K
Free Cash Flow $1.073M -$7.015M
YoY Change -115.3% -135.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129490000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123658000 USD
CY2015Q1 us-gaap Short Term Investments
ShortTermInvestments
24913000 USD
CY2015Q2 us-gaap Short Term Investments
ShortTermInvestments
21368000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86368000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88076000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14727000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12121000 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11002000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11602000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
266500000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
256825000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28264000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27587000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
8607000 USD
CY2015Q2 us-gaap Goodwill
Goodwill
8607000 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
24612000 USD
CY2015Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
25917000 USD
CY2015Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
36195000 USD
CY2015Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
37148000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1121000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1159000 USD
CY2015Q1 us-gaap Assets
Assets
365299000 USD
CY2015Q2 us-gaap Assets
Assets
357243000 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8935000 USD
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8933000 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62184000 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40169000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8226000 USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5776000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
79345000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54878000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1862000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1985000 USD
CY2015Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
37745000 USD
CY2015Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
44648000 USD
CY2015Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2059000 USD
CY2015Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1914000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
121011000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
103425000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
160225000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-904000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1412000 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
174161000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
14000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
7000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-918000 USD
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1419000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
246961000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
248089000 USD
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
162010000 USD
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
167036000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
244288000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
253818000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
365299000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
357243000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
45478000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
48940000 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114239000 USD
CY2015Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
114226000 USD
CY2015Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
45394000 USD
CY2015Q2 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
51419000 USD
CY2015Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
45394000 USD
CY2015Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
51419000 USD
CY2015Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
18739000 USD
CY2015Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
2618000 USD
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
21357000 USD
CY2015Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
18750000 USD
CY2015Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
2618000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3386000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3596000 USD
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16427000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3556000 shares
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
3436000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13311000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13537000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13695000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13940000 shares
CY2015Q2 expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2012Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2015Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
40483 shares
CY2014Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
102719 shares
CY2015Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3500000 USD
CY2014Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7631000 USD
CY2015Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
31578000 USD
CY2015Q2 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
CY2014Q2 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
6050000 USD
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
390000 USD
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
428000 USD
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000 USD
CY2015Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6169000 USD
CY2014Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6008000 USD
CY2015Q2 us-gaap Revenues
Revenues
80293000 USD
CY2014Q2 us-gaap Revenues
Revenues
75962000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15028000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14094000 USD
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1381000 USD
CY2014Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1322000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
72967000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3488000 USD
CY2015Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6510000 USD
CY2015Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4152000 USD
CY2014Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
2995000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3698000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
65265000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
61868000 USD
CY2015Q2 us-gaap Investment Income Net
InvestmentIncomeNet
34000 USD
CY2014Q2 us-gaap Investment Income Net
InvestmentIncomeNet
44000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2009000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1227000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2043000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1271000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17071000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15365000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6738000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6211000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
10333000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
9154000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.68
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2015Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3
CY2014Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2015Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2015Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2015Q2 us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
CY2015Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-501000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
52000 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9825000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9220000 USD
CY2015Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-213000 USD
CY2014Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-225000 USD
CY2015Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-145000 USD
CY2014Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-99000 USD
CY2015Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
390000 USD
CY2014Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
249000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5221000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5293000 USD
CY2015Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1938000 USD
CY2014Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3324000 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4431000 USD
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4499000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2098000 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8215000 USD
CY2015Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2689000 USD
CY2014Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4988000 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4553000 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8167000 USD
CY2015Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12017000 USD
CY2014Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9838000 USD
CY2015Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2450000 USD
CY2014Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
433000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1701000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6120000 USD
CY2015Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
627000 USD
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
915000 USD
CY2015Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
3320000 USD
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3858000 USD
CY2014Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
1140000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2693000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
225000 USD
CY2015Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4431000 USD
CY2014Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4499000 USD
CY2015Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7267000 USD
CY2014Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6267000 USD
CY2015Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3500000 USD
CY2014Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6831000 USD
CY2015Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
289000 USD
CY2014Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
329000 USD
CY2015Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
4023000 USD
CY2014Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
3310000 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-10070000 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-11580000 USD
CY2015Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-156000 USD
CY2014Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
148000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5832000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17327000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122948000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105621000 USD
CY2015Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2014Q2 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
800000 USD
CY2015Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
154380000 USD
CY2015Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
145015000 USD
CY2015Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
154403000 USD
CY2015Q2 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
145026000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.3
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2015Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
27000 USD
CY2015Q2 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2015Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4000 USD
CY2015Q2 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
2000 USD
CY2015Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2015Q1 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q2 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2015Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2014Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares

Files In Submission

Name View Source Status
0001144204-15-028813-index-headers.html Edgar Link pending
0001144204-15-028813-index.html Edgar Link pending
0001144204-15-028813.txt Edgar Link pending
0001144204-15-028813-xbrl.zip Edgar Link pending
expo-20150403.xml Edgar Link completed
expo-20150403.xsd Edgar Link pending
expo-20150403_cal.xml Edgar Link unprocessable
expo-20150403_def.xml Edgar Link unprocessable
expo-20150403_lab.xml Edgar Link unprocessable
expo-20150403_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v408371_10q.htm Edgar Link pending
v408371_ex31-1.htm Edgar Link pending
v408371_ex31-2.htm Edgar Link pending
v408371_ex32-1.htm Edgar Link pending
v408371_ex32-2.htm Edgar Link pending